Sirolimus use in de "novo renal" transplantation
Nefrologia. 2006:26 Suppl 2:33-51.
[Article in
English,
Spanish]
Authors
J M Grinyo
1
, A Alonso, M Arias, J M Campistol, M González Molina, J M González Posada, J M Morales, F Oppenheimer, A Sánchez Fructuoso, J Sánchez-Plumed, J C Ruiz
No abstract available
MeSH terms
-
Adrenal Cortex Hormones / administration & dosage
-
Adrenal Cortex Hormones / adverse effects
-
Adrenal Cortex Hormones / therapeutic use
-
Adult
-
Animals
-
Antibodies, Monoclonal / administration & dosage
-
Antibodies, Monoclonal / therapeutic use
-
Antilymphocyte Serum / administration & dosage
-
Antilymphocyte Serum / therapeutic use
-
Calcineurin Inhibitors
-
Child
-
Cyclosporine / administration & dosage
-
Cyclosporine / adverse effects
-
Cyclosporine / therapeutic use
-
Double-Blind Method
-
Drug Interactions
-
Drug Therapy, Combination
-
Europe
-
Humans
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use*
-
Kidney Diseases / chemically induced
-
Kidney Transplantation / immunology*
-
Multicenter Studies as Topic / statistics & numerical data
-
Randomized Controlled Trials as Topic / statistics & numerical data
-
Rats
-
Registries
-
Sirolimus / administration & dosage
-
Sirolimus / adverse effects
-
Sirolimus / therapeutic use*
-
Tacrolimus / administration & dosage
-
Tacrolimus / adverse effects
-
Tacrolimus / therapeutic use
-
United States
Substances
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal
-
Antilymphocyte Serum
-
Calcineurin Inhibitors
-
Immunosuppressive Agents
-
Cyclosporine
-
thymoglobulin
-
Sirolimus
-
Tacrolimus